AEDIFICA (AED.BR) Stock Fundamental Analysis

EBR:AED • BE0003851681

78.25 EUR
-1 (-1.26%)
Last: Feb 19, 2026, 01:31 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AED. AED was compared to 41 industry peers in the Diversified REITs industry. There are concerns on the financial health of AED while its profitability can be described as average. AED is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year AED was profitable.
  • AED had a positive operating cash flow in the past year.
  • In the past 5 years AED has always been profitable.
  • In the past 5 years AED always reported a positive cash flow from operatings.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • AED's Return On Assets of 2.73% is in line compared to the rest of the industry. AED outperforms 58.54% of its industry peers.
  • AED has a Return On Equity (4.96%) which is in line with its industry peers.
  • AED has a Return On Invested Capital (3.52%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for AED is in line with the industry average of 3.45%.
  • The 3 year average ROIC (3.33%) for AED is below the current ROIC(3.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROIC 3.52%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 49.82%, AED is in the better half of the industry, outperforming 65.85% of the companies in the same industry.
  • AED's Profit Margin has declined in the last couple of years.
  • The Operating Margin of AED (77.70%) is better than 70.73% of its industry peers.
  • AED's Operating Margin has been stable in the last couple of years.
  • AED has a Gross Margin of 97.93%. This is amongst the best in the industry. AED outperforms 97.56% of its industry peers.
  • AED's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AED is destroying value.
  • AED has about the same amout of shares outstanding than it did 1 year ago.
  • AED has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, AED has a worse debt to assets ratio.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.94, we must say that AED is in the distress zone and has some risk of bankruptcy.
  • AED has a Altman-Z score of 0.94. This is comparable to the rest of the industry: AED outperforms 58.54% of its industry peers.
  • AED has a debt to FCF ratio of 24.91. This is a negative value and a sign of low solvency as AED would need 24.91 years to pay back of all of its debts.
  • AED's Debt to FCF ratio of 24.91 is on the low side compared to the rest of the industry. AED is outperformed by 68.29% of its industry peers.
  • A Debt/Equity ratio of 0.58 indicates that AED is somewhat dependend on debt financing.
  • AED has a Debt to Equity ratio of 0.58. This is in the better half of the industry: AED outperforms 65.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Altman-Z 0.94
ROIC/WACC0.56
WACC6.29%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • AED has a Current Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AED has a Current ratio of 0.35. This is comparable to the rest of the industry: AED outperforms 41.46% of its industry peers.
  • A Quick Ratio of 0.35 indicates that AED may have some problems paying its short term obligations.
  • AED's Quick ratio of 0.35 is in line compared to the rest of the industry. AED outperforms 46.34% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

  • AED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.94%, which is quite impressive.
  • AED shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.20% yearly.
  • AED shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.06%.
  • Measured over the past years, AED shows a very strong growth in Revenue. The Revenue has been growing by 23.35% on average per year.
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%

3.2 Future

  • AED is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.19% yearly.
  • AED is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.12% yearly.
EPS Next Y4.17%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
EPS Next 5YN/A
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.34 indicates a correct valuation of AED.
  • AED's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of AED to the average of the S&P500 Index (27.27), we can say AED is valued slightly cheaper.
  • AED is valuated correctly with a Price/Forward Earnings ratio of 14.89.
  • Based on the Price/Forward Earnings ratio, AED is valued a bit more expensive than the industry average as 65.85% of the companies are valued more cheaply.
  • AED is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.34
Fwd PE 14.89
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • AED's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AED is more expensive than 65.85% of the companies in the same industry.
  • 80.49% of the companies in the same industry are cheaper than AED, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 35.9
EV/EBITDA 22.68
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AED does not grow enough to justify the current Price/Earnings ratio.
  • AED has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.92
PEG (5Y)N/A
EPS Next 2Y3.32%
EPS Next 3Y3.19%

3

5. Dividend

5.1 Amount

  • AED has a Yearly Dividend Yield of 3.68%.
  • Compared to an average industry Dividend Yield of 5.33, AED is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.85, AED pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

  • The dividend of AED is nicely growing with an annual growth rate of 22.82%!
Dividend Growth(5Y)22.82%
Div Incr Years1
Div Non Decr Years1
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • AED pays out 105.58% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP105.58%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AEDIFICA

EBR:AED (2/19/2026, 1:31:02 PM)

78.25

-1 (-1.26%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-13
Earnings (Next)04-27
Inst Owners41.34%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap3.72B
Revenue(TTM)358.28M
Net Income(TTM)175.81M
Analysts82.22
Price Target80.37 (2.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP105.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.95%
PT rev (3m)7.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.62%
EPS NY rev (3m)0.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 16.34
Fwd PE 14.89
P/S 10.54
P/FCF 35.9
P/OCF 12.74
P/B 1.05
P/tB 1.08
EV/EBITDA 22.68
EPS(TTM)4.79
EY6.12%
EPS(NY)5.26
Fwd EY6.72%
FCF(TTM)2.18
FCFY2.79%
OCF(TTM)6.14
OCFY7.85%
SpS7.42
BVpS74.59
TBVpS72.74
PEG (NY)3.92
PEG (5Y)N/A
Graham Number89.66
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROCE 4.69%
ROIC 3.52%
ROICexc 3.55%
ROICexgc 3.61%
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
FCFM 29.37%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexgc growth 3Y6.29%
ROICexgc growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Debt/EBITDA 7.41
Cap/Depr 6078.86%
Cap/Sales 53.38%
Interest Coverage 250
Cash Conversion 105.31%
Profit Quality 58.95%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.94
F-Score7
WACC6.29%
ROIC/WACC0.56
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
EPS Next Y4.17%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
EPS Next 5YN/A
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year10.51%
EBIT Next 3Y6.39%
EBIT Next 5YN/A
FCF growth 1Y142.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3Y7.82%
OCF growth 5Y22.86%

AEDIFICA / AED.BR FAQ

What is the fundamental rating for AED stock?

ChartMill assigns a fundamental rating of 4 / 10 to AED.BR.


What is the valuation status of AEDIFICA (AED.BR) stock?

ChartMill assigns a valuation rating of 2 / 10 to AEDIFICA (AED.BR). This can be considered as Overvalued.


How profitable is AEDIFICA (AED.BR) stock?

AEDIFICA (AED.BR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for AED stock?

The Price/Earnings (PE) ratio for AEDIFICA (AED.BR) is 16.34 and the Price/Book (PB) ratio is 1.05.


Can you provide the financial health for AED stock?

The financial health rating of AEDIFICA (AED.BR) is 2 / 10.